Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 9;15(10):1204.
doi: 10.3390/diagnostics15101204.

The Prevalence and Significance of Incidental Positron Emission Tomography Findings in the Brain Using Radiotracers Other than [18F]FDG: A Systematic Review and Meta-Analysis

Cesare Michele Iacovitti  1 , Barbara Muoio  2   3 , Domenico Albano  4 , Alessio Rizzo  5 , Marco Cuzzocrea  1 , Gaetano Paone  1   3 , Giorgio Treglia  1   3   6
Affiliations
Review

The Prevalence and Significance of Incidental Positron Emission Tomography Findings in the Brain Using Radiotracers Other than [18F]FDG: A Systematic Review and Meta-Analysis

Cesare Michele Iacovitti et al. Diagnostics (Basel). .

Abstract

Background: Incidental brain imaging findings could be clinically relevant, and advancements in molecular imaging could lead to their more frequent identification. The aim of this review is to establish the prevalence and clinical significance of brain incidentalomas at PET (BIPs) using radiotracers other than [18F]FDG. Methods: A comprehensive literature search of studies about BIPs was carried out. Four different databases (PubMed/MEDLINE, EMBASE, the Cochrane library, and Google Scholar) were screened up to December 2024. Only original articles about BIPs using radiotracers other than [18F]FDG were selected. A proportion meta-analysis of the prevalence of BIPs was carried out using a random-effects model. Results: Fourteen studies were included in the review, using somatostatin receptor (SSTR) PET (n = 6), radiolabeled choline PET (n = 5), prostate-specific membrane antigen (PSMA) ligands PET (n = 1), [18F]Fluciclovine PET (n = 1), and [18F]FDOPA PET (n = 1). The pooled prevalence of BIPs was 4.6% for SSTR PET, 1.1% for choline PET, 1.2% for PSMA ligands PET, 2.5% for [18F]Fluciclovine PET, and 3.9% for [18F]FDOPA PET. When BIPs were further evaluated using MRI, meningiomas were the most frequent lesions detected, but both benign and malignant lesions could be incidentally diagnosed. Conclusions: BIPs using radiotracers other than [18F]FDG are not rare, in particular at SSTR PET, further justifying the extension of PET scans to the brain when radiotracers other than [18F]FDG are used. When detected, a BIP should be further evaluated using brain MRI. Both benign and malignant lesions could be incidentally detected in the brain. Further studies are warranted to better clarify the clinical impact of BIP detection.

Keywords: PET; brain lesions; brain metastases; brain tumors; incidental; incidentalomas; meningioma; neuro-oncology; neuroimaging; nuclear medicine; positron emission tomography.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
A case of brain incidental finding (yellow arrow) at somatostatin receptor PET/CT with [68Ga]Ga-DOTA-peptides detected at maximum-intensity projection PET image (A), axial (B), coronal (C), and sagittal (D) PET/CT images.
Figure 2
Figure 2
Results of the literature search.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. O’Sullivan J.W., Muntinga T., Grigg S., Ioannidis J.P.A. Prevalence and outcomes of incidental imaging findings: Umbrella review. BMJ. 2018;361:k2387. doi: 10.1136/bmj.k2387. - DOI - PMC - PubMed
    1. Alabousi M., Wilson E., Al-Ghetaa R.K., Patlas M.N. General Review on the Current Management of Incidental Findings on Cross-Sectional Imaging: What Guidelines to Use, How to Follow Them, and Management and Medical-Legal Considerations. Radiol. Clin. N. Am. 2021;59:501–509. doi: 10.1016/j.rcl.2021.03.002. - DOI - PubMed
    1. Juweid M.E., Al-Qasem S.F., Khuri F.R., Gallamini A., Lohmann P., Ziellenbach H.J., Mottaghy F.M. Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine. CA Cancer J. Clin. 2025 doi: 10.3322/caac.70007. - DOI - PMC - PubMed
    1. Skotting M.B., Holst A.V., Munch T.N. Incidental findings in MRI of the brain. Ugeskr. Læger. 2024;186:V12230770. doi: 10.61409/V12230770. - DOI - PubMed
    1. Wangaryattawanich P., Rutman A.M., Petcharunpaisan S., Mossa-Basha M. Incidental findings on brain magnetic resonance imaging (MRI) in adults: A review of imaging spectrum, clinical significance, and management. Br. J. Radiol. 2023;96:20220108. doi: 10.1259/bjr.20220108. - DOI - PMC - PubMed

LinkOut - more resources